Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | German |
| Veröffentlicht: |
Tübingen
1981
|
| Schlagworte: | |
| Beschreibung: | Tübingen, Univ., Diss., 1981 |
| Beschreibung: | VI, 115 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV002140373 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 890928s1981 d||| m||| 00||| ger d | ||
| 035 | |a (OCoLC)603944059 | ||
| 035 | |a (DE-599)BVBBV002140373 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-91 | ||
| 100 | 1 | |a Türck, Michael |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium |
| 264 | 1 | |a Tübingen |c 1981 | |
| 300 | |a VI, 115 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Tübingen, Univ., Diss., 1981 | ||
| 650 | 4 | |a ANIMAL EXPERIMENTS/DRUG ANALYSIS AND DRUG ACTION (PHARMACOLOGY) | |
| 650 | 4 | |a EXPERIÉNCES SUR ANIMAUX/EFFET ET ANALYSE DES MÉDICAMENTS | |
| 650 | 4 | |a LITHIUM-CONTAINING DRUGS (PHARMACY) | |
| 650 | 4 | |a LITHIUMHALTIGE ARZNEIMITTEL | |
| 650 | 4 | |a MONOAMINE, CATECHOLAMINE (NEUROLOGIE) | |
| 650 | 4 | |a MONOAMINES (NEUROPHYSIOLOGIE) | |
| 650 | 4 | |a MONOAMINES, CATECHOLAMINES (NEUROLOGY) | |
| 650 | 4 | |a MÉDICAMENTS CONTENANT DU LITHIUM | |
| 650 | 4 | |a NEUROPHARMACOLOGIE + AGENTS NEUROPHARMACEUTIQUES | |
| 650 | 4 | |a NEUROPHARMACOLOGY + NEURO-PHARMACEUTICALS | |
| 650 | 4 | |a NEUROPHARMAKA + NEUROPHARMAKOLOGIE | |
| 650 | 4 | |a TIERVERSUCHE/ARZNEIMITTELWIRKUNG UND -ANALYSE | |
| 650 | 0 | 7 | |a Imipramin |0 (DE-588)4161339-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lithium |0 (DE-588)4036037-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Imipramin |0 (DE-588)4161339-9 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Lithium |0 (DE-588)4036037-4 |D s |
| 689 | 1 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-001403748 | ||
Datensatz im Suchindex
| _version_ | 1804116594582880256 |
|---|---|
| any_adam_object | |
| author | Türck, Michael |
| author_facet | Türck, Michael |
| author_role | aut |
| author_sort | Türck, Michael |
| author_variant | m t mt |
| building | Verbundindex |
| bvnumber | BV002140373 |
| ctrlnum | (OCoLC)603944059 (DE-599)BVBBV002140373 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01917nam a2200517 c 4500</leader><controlfield tag="001">BV002140373</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890928s1981 d||| m||| 00||| ger d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)603944059</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV002140373</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Türck, Michael</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Tübingen</subfield><subfield code="c">1981</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VI, 115 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Tübingen, Univ., Diss., 1981</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ANIMAL EXPERIMENTS/DRUG ANALYSIS AND DRUG ACTION (PHARMACOLOGY)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">EXPERIÉNCES SUR ANIMAUX/EFFET ET ANALYSE DES MÉDICAMENTS</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">LITHIUM-CONTAINING DRUGS (PHARMACY)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">LITHIUMHALTIGE ARZNEIMITTEL</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">MONOAMINE, CATECHOLAMINE (NEUROLOGIE)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">MONOAMINES (NEUROPHYSIOLOGIE)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">MONOAMINES, CATECHOLAMINES (NEUROLOGY)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">MÉDICAMENTS CONTENANT DU LITHIUM</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">NEUROPHARMACOLOGIE + AGENTS NEUROPHARMACEUTIQUES</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">NEUROPHARMACOLOGY + NEURO-PHARMACEUTICALS</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">NEUROPHARMAKA + NEUROPHARMAKOLOGIE</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">TIERVERSUCHE/ARZNEIMITTELWIRKUNG UND -ANALYSE</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Imipramin</subfield><subfield code="0">(DE-588)4161339-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lithium</subfield><subfield code="0">(DE-588)4036037-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Imipramin</subfield><subfield code="0">(DE-588)4161339-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Lithium</subfield><subfield code="0">(DE-588)4036037-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001403748</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV002140373 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:41:00Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001403748 |
| oclc_num | 603944059 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | VI, 115 S. graph. Darst. |
| publishDate | 1981 |
| publishDateSearch | 1981 |
| publishDateSort | 1981 |
| record_format | marc |
| spelling | Türck, Michael Verfasser aut Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium Tübingen 1981 VI, 115 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Tübingen, Univ., Diss., 1981 ANIMAL EXPERIMENTS/DRUG ANALYSIS AND DRUG ACTION (PHARMACOLOGY) EXPERIÉNCES SUR ANIMAUX/EFFET ET ANALYSE DES MÉDICAMENTS LITHIUM-CONTAINING DRUGS (PHARMACY) LITHIUMHALTIGE ARZNEIMITTEL MONOAMINE, CATECHOLAMINE (NEUROLOGIE) MONOAMINES (NEUROPHYSIOLOGIE) MONOAMINES, CATECHOLAMINES (NEUROLOGY) MÉDICAMENTS CONTENANT DU LITHIUM NEUROPHARMACOLOGIE + AGENTS NEUROPHARMACEUTIQUES NEUROPHARMACOLOGY + NEURO-PHARMACEUTICALS NEUROPHARMAKA + NEUROPHARMAKOLOGIE TIERVERSUCHE/ARZNEIMITTELWIRKUNG UND -ANALYSE Imipramin (DE-588)4161339-9 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Lithium (DE-588)4036037-4 gnd rswk-swf (DE-588)4113937-9 Hochschulschrift gnd-content Imipramin (DE-588)4161339-9 s Pharmakologie (DE-588)4045687-0 s DE-604 Lithium (DE-588)4036037-4 s |
| spellingShingle | Türck, Michael Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium ANIMAL EXPERIMENTS/DRUG ANALYSIS AND DRUG ACTION (PHARMACOLOGY) EXPERIÉNCES SUR ANIMAUX/EFFET ET ANALYSE DES MÉDICAMENTS LITHIUM-CONTAINING DRUGS (PHARMACY) LITHIUMHALTIGE ARZNEIMITTEL MONOAMINE, CATECHOLAMINE (NEUROLOGIE) MONOAMINES (NEUROPHYSIOLOGIE) MONOAMINES, CATECHOLAMINES (NEUROLOGY) MÉDICAMENTS CONTENANT DU LITHIUM NEUROPHARMACOLOGIE + AGENTS NEUROPHARMACEUTIQUES NEUROPHARMACOLOGY + NEURO-PHARMACEUTICALS NEUROPHARMAKA + NEUROPHARMAKOLOGIE TIERVERSUCHE/ARZNEIMITTELWIRKUNG UND -ANALYSE Imipramin (DE-588)4161339-9 gnd Pharmakologie (DE-588)4045687-0 gnd Lithium (DE-588)4036037-4 gnd |
| subject_GND | (DE-588)4161339-9 (DE-588)4045687-0 (DE-588)4036037-4 (DE-588)4113937-9 |
| title | Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium |
| title_auth | Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium |
| title_exact_search | Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium |
| title_full | Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium |
| title_fullStr | Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium |
| title_full_unstemmed | Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium |
| title_short | Beeinflussung monoaminerger Transmittersysteme im Rattengehirn durch Imipramin und Lithium |
| title_sort | beeinflussung monoaminerger transmittersysteme im rattengehirn durch imipramin und lithium |
| topic | ANIMAL EXPERIMENTS/DRUG ANALYSIS AND DRUG ACTION (PHARMACOLOGY) EXPERIÉNCES SUR ANIMAUX/EFFET ET ANALYSE DES MÉDICAMENTS LITHIUM-CONTAINING DRUGS (PHARMACY) LITHIUMHALTIGE ARZNEIMITTEL MONOAMINE, CATECHOLAMINE (NEUROLOGIE) MONOAMINES (NEUROPHYSIOLOGIE) MONOAMINES, CATECHOLAMINES (NEUROLOGY) MÉDICAMENTS CONTENANT DU LITHIUM NEUROPHARMACOLOGIE + AGENTS NEUROPHARMACEUTIQUES NEUROPHARMACOLOGY + NEURO-PHARMACEUTICALS NEUROPHARMAKA + NEUROPHARMAKOLOGIE TIERVERSUCHE/ARZNEIMITTELWIRKUNG UND -ANALYSE Imipramin (DE-588)4161339-9 gnd Pharmakologie (DE-588)4045687-0 gnd Lithium (DE-588)4036037-4 gnd |
| topic_facet | ANIMAL EXPERIMENTS/DRUG ANALYSIS AND DRUG ACTION (PHARMACOLOGY) EXPERIÉNCES SUR ANIMAUX/EFFET ET ANALYSE DES MÉDICAMENTS LITHIUM-CONTAINING DRUGS (PHARMACY) LITHIUMHALTIGE ARZNEIMITTEL MONOAMINE, CATECHOLAMINE (NEUROLOGIE) MONOAMINES (NEUROPHYSIOLOGIE) MONOAMINES, CATECHOLAMINES (NEUROLOGY) MÉDICAMENTS CONTENANT DU LITHIUM NEUROPHARMACOLOGIE + AGENTS NEUROPHARMACEUTIQUES NEUROPHARMACOLOGY + NEURO-PHARMACEUTICALS NEUROPHARMAKA + NEUROPHARMAKOLOGIE TIERVERSUCHE/ARZNEIMITTELWIRKUNG UND -ANALYSE Imipramin Pharmakologie Lithium Hochschulschrift |
| work_keys_str_mv | AT turckmichael beeinflussungmonoaminergertransmittersystemeimrattengehirndurchimipraminundlithium |